3rd Circ. Affirms FDA Ban On Ephedrine Products
The U.S. Court of Appeals for the Third Circuit on Tuesday concluded that the FDA ban was properly conceived and that the agency's seizure of ephedrine-containing supplements made by Hi-Tech Pharmaceuticals Inc., the appellant in the case, was legal.
In doing so,...
To view the full article, register now.